APA (7th ed.) Citation

JS, E., MW, K., JL, T., I, F., A, H., S, S., . . . SM, R. (2021). Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 20(6), 1026. https://doi.org/10.1016/j.jcf.2021.08.007

Chicago Style (17th ed.) Citation

JS, Elborn, et al. "Empire-CF Study: A Phase 2 Clinical Trial of Leukotriene A4 Hydrolase Inhibitor Acebilustat in Adult Subjects with Cystic Fibrosis." Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society 20, no. 6 (2021): 1026. https://doi.org/10.1016/j.jcf.2021.08.007.

MLA (9th ed.) Citation

JS, Elborn, et al. "Empire-CF Study: A Phase 2 Clinical Trial of Leukotriene A4 Hydrolase Inhibitor Acebilustat in Adult Subjects with Cystic Fibrosis." Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, vol. 20, no. 6, 2021, p. 1026, https://doi.org/10.1016/j.jcf.2021.08.007.